Company / PP&E (Net)
Tyra Biosciences, Inc. PP&E (Net) History
FY2020-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E (Net)
$1.7M
FY2024
5-year range
$297.0K / $1.7M
FY2020-FY2024
Trend
+1.4%
vs FY2023
Sector context
#142 of 193
Health Care
What the data says
At $2M, Tyra Biosciences, Inc.'s pp&e (net) ranks #142 of 193 in the Health Care sector. PP&E (Net) has increased for 4 consecutive years, from $297,000 in FY2020 to $2M in FY2024.
Based on SEC 10-K filings.
$2M in FY2024 with a 3-year CAGR of +17.1%.
Improved from $1M to $2M over the past 2 years.
Health Care sector context is included.
PP&E (Net) over time
Growth rates
- 3-Year CAGR
- +17.1%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#142 of 193 in Health CareTop 74% of 193This company $1.7M Sector average $777.6M
▼
-99.8% below sector average
Key checks
Key Insights
- Tyra Biosciences, Inc.'s pp&e (net) has grown for 4 consecutive years.
- 3-year CAGR of +17.1%, indicating consistent growth.
- In FY2024, pp&e (net) increased 1.4% year-over-year.
- Ranks #142 out of 193 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 6.83 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E (Net)Value | YoY GrowthYoY |
|---|---|---|
| FY2024 | $1.7M | +1.4% |
| FY2023 | $1.6M | +51.2% |
| FY2022 | $1.1M | +4.9% |
| FY2021 | $1.0M | +245.8% |
| FY2020 | $297.0K | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026